<DOC>
	<DOC>NCT02084069</DOC>
	<brief_summary>The purpose of the investigation is to determine whether Atrovastatin as anti-inflammatory agent can be effective in preventing from atrial fibrillation incidence in patients whom undergone open cardiac surgery for their heart valve repair.</brief_summary>
	<brief_title>Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair</brief_title>
	<detailed_description />
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Greater than 25 y/o No occurrence of intra or postoperative cardiopulmonary arrest Not consuming drugs affecting atrial rhythm Having sinus rhythm before surgery Lack of paroxysmal atrial fibrillation history Only undergo heart valve surgery Lack of considerable heart ischemia needed atorvastatin use Routine cares in ward, postoperative ward, and intensive care unit were done Lesser than 25 y/o History of atrial fibrillation History of taking antiarrhythmic drugs History of implementing pacemakers Severe heart failure Renal failure Hepatic failure Severe pulmonary diseases Heart block or bradyarrhythmia Routine cares in ward, postoperative ward, and intensive care unit were not done Performing concomitant cardiac surgery except valve repair Having considerable heart ischemia needed atorvastatin use</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>